Stay updated on Immuno-Therapy in Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.

Latest updates to the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page
- Check7 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer now lists site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check34 days agoChange DetectedThe study page now renders a 403 Forbidden error, replacing the usual study record content and navigation and making the trial details inaccessible.SummaryDifference18%

- Check56 days agoChange DetectedRevision label on the page updated from v3.6.5 to v3.6.6, indicating a software version increment. No study content changes are reflected in the provided data.SummaryDifference0.0%

- Check63 days agoChange DetectedA new NIH funding reference line, '2015 ( U.S. NIH Grant/Contract )', was added to the Study ID Numbers section to indicate the grant source for the study.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a new build/version of the site content.SummaryDifference0.0%

Stay in the know with updates to Immuno-Therapy in Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.